GSK Renews Site License for Golden Helix's Software | GenomeWeb
NEW YORK (GenomeWeb News) - Golden Helix said today that GlaxoSmithKline has renewed a site license for its HelixTree genetic analysis software.
HelixTree is a statistical analysis package for analyzing data from whole-genome association studies.
Golden Helix said it initially developed the software in 1998 through a collaboration with GSK.
Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.